Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion strategies: opportunities for improvement

J E Menitove1

  • 1Hoxworth Blood Center, University of Cincinnati College of Medicine, OH 45267-0055, USA.

Immunological Investigations
|January 1, 1995
PubMed
Summary

Optimizing transfusion therapy, including donor sources for platelet concentrates and advanced leukocyte-reduction filters, can improve patient care. Incorporating platelet crossmatching into transfusion algorithms is also suggested for enhanced clinical practice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ISBT Code 128 implementation at a regional blood center.

Transfusion·2005
Same author

Immunoprophylaxis for D- patients receiving platelet transfusions from D- donors? Transfusion. 2002;42:136-8.

Transfusion·2002
Same author

Haemovigilance systems.

Vox sanguinis·1999
Same author

A feasibility evaluation of an automated blood component collection system platelets and red cells.

Transfusion·1999
Same author

Platelet transfusion practice: time for renewed consensus.

Transfusion·1998
Same author

Hemovigilance in the United States of America.

Vox sanguinis·1998

Area of Science:

  • Transfusion Medicine
  • Hematology
  • Clinical Technology

Background:

  • Current transfusion practices offer opportunities for enhancement through patient care improvements and technological integration.
  • Platelet concentrates can be sourced from single donors (plateletapheresis) or random donors (pooled from whole blood donations).

Purpose of the Study:

  • To discuss advancements in transfusion practice focusing on patient care, technology, and clinical arena changes.
  • To present the benefits of third-generation leukocyte-reduction filters for consistent leukocyte-reduced blood components.
  • To suggest incorporating platelet crossmatching into clinical practice and transfusion algorithms.

Main Methods:

  • Review of current transfusion practices and technological advancements.

Related Experiment Videos

  • Discussion of optimizing platelet concentrate sourcing (single donor vs. random donor).
  • Evaluation of third-generation leukocyte-reduction filters and platelet crossmatching technology.

    • Main Results:

    • Third-generation leukocyte-reduction filters offer significant and consistent reduction of leukocytes in blood components.
    • Platelet crossmatching is identified as a key technological change impacting clinical practice.
    • Optimizing transfusion therapy and donor sources can enhance patient care.

    Conclusions:

    • Improvements in transfusion practice can be achieved through optimizing therapy, donor selection, and adopting new technologies.
    • Leukocyte-reduced blood components are more consistently achievable with advanced filters.
    • Platelet crossmatching integration into transfusion algorithms is recommended for improved clinical outcomes.